Statement on the Safeguard American Voter Eligibility (SAVE) Act

On March 17, 2026, the U.S. Senate began discussions on the Safeguard American Voter Eligibility (SAVE) Act, which aims to address allegations of widespread voter fraud and election integrity by introducing more stringent requirements for personal identification and proof of citizenship. However, this may impose additional barriers by shifting the burden of proving eligibility to the individual voter, potentially reducing civic participation.

 

What changes are proposed?

The SAVE Act requires:

  1. Proof of U.S. citizenship using a birth certificate, passport, or naturalization certificate for voter registration
  2. A government-issued photo identification for requesting and submitting mail-in ballots
  3. States to verify voter eligibility through federal databases in coordination with the Department of Homeland Security

 

How could this affect you?

 

Why does this matter?

National APAMSA strongly condemns this bill due to its potential to create barriers to civic participation and equitable access to voting. These changes may disproportionately impact communities with limited access to documentation, including naturalized citizens and historically marginalized populations. In alignment with our policy compendium and as mentioned in previous statements, National APAMSA recognizes that access to voting is a critical social determinant of health, with direct implications for both individual and community well-being. 

 

What can you do?

We urge you to contact your local senator to express your opposition to the SAVE Act. Resources such as 5 Calls and When We All Vote can help you find and reach your elected officials.

For questions regarding this statement, please contact the Rapid Response Director, Pehr Williamson at rapidresponse@apamsa.org



Alumni of the Year Award 2026

Congratulations to our 2026 Alumni of the Year: Lindy Zhang, M.D., Ph.D.

This award honors her enthusiastic participation in the APAMSA Alumni Advisory Board, commitment to AANHPI research, and dedication to mentoring APAMSA students.

Lindy Zhang, M.D., Ph.D. is Assistant Professor of Oncology and Pediatrics in the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She is a child of immigrants and the first in her family to pursue a post-bachelor’s degree. Dr. Zhang completed her medical degree at the Albert Einstein College of Medicine with distinction in clinical research and her pediatrics residency at the Johns Hopkins Children’s Center. She then pursued a pediatric hematology-oncology fellowship at the combined Johns Hopkins-National Cancer Institute program. During her fellowship, she received additional translational research training by completing a PhD in Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. Her research focuses on NF1-associated tumors and the application of molecularly targeted therapies. Her academic interest is to define the interactions between molecularly targeted agents and the tumor immune microenvironment in malignant peripheral nerve sheath tumors (MPNST) and establish the potential role of immune-based therapies in novel therapeutic combinations. In addition, Dr. Zhang is passionate about diversity and inclusion in academic medicine. Her medical education research focuses on Asian American representation and experiences of microaggression and discrimination in medical school.

To read more about the APAMSA Alumni of the Year Award, click here.

Questions? Please reach out to strategy@apamsa.org



Andy Lai

Network Director


Lam Tran

Network Director